USPTO serial 50153218
PRIORA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- —
- Law office
- —
What this means
Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.
Need help with PRIORA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
North Caldwell, NJ, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Carissa L. Weiss
Carissa L. Weiss Law Office of Carissa L. Weiss, PLLC745 Fifth Avenue, Suite 500New York, NY 10151United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Scientific research; Medical and scientific research in the field of health, medicine, pharmaceutical development, genetics and bioinformatics; Medical and scientific research in the field of predicting and preventing diseases, tracking individual health status, and tracking disease risk; Genetic testing for scientific research purposes; Technological research relating to genetic testing; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Consulting services for others in the field of design, planning, and implementation project management of scientific research, optimization of clinical trials, and repurposing of pharmaceuticals; Providing on-line non-downloadable software using artificial intelligence (AI) for genetic testing, health tracking, predicting medical risk, predicting and preventing diseases, tracking individual health status, tracking disease risk, facilitating clinical decision making, and providing medical information and advice; Providing on-line non-downloadable software using artificial intelligence (AI) for data management, data storage, data analysis and report generation in the field of health, medicine, pharmaceutical development and repurposing, genetics and bioinformatics; Providing online non-downloadable virtual assistant software using artificial intelligence (AI) for data management, data storage, data analysis and report generation in the field of health, medicine, pharmaceutical development and repurposing, genetics and bioinformatics; Providing online non-downloadable virtual assistant software using artificial intelligence (AI) for genetic testing, health tracking, predicting medical risk, predicting and preventing diseases, tracking individual health status, tracking disease risk, facilitating clinical decision making, and providing medical information and advice; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for genetic testing, health tracking, predicting medical risk, predicting and preventing diseases, tracking individual health status, tracking disease risk, facilitating clinical decision making, and providing medical information and advice; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for data management, data storage, data analysis and report generation in the field of health, medicine, pharmaceutical development and repurposing, genetics and bioinformatics | ACTIVE | — |
| 044 | Medical services; Medical diagnostic services; Medical screening; Medical testing services; Medical information; Health counseling; Genetic counseling; Providing personalized healthcare and medical information in the nature of medical and healthcare recommendations based on individual health and genetic data; Providing personalized healthcare and medical information in the nature of recommendations for predicting and preventing diseases, tracking individual health status, tracking disease risk, facilitating clinical decision making, and enhancing health conversations with artificial intelligence (AI) assistants; Genetic testing for medical purposes; Providing information about genetic testing for medical purposes; Medical services, namely, using biological data to predict and prevent diseases, track individual health status, track disease risk, facilitate clinical decision making, and enhance health conversations with artificial intelligence (AI) assistants | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 9, 2026 | NWAP | NEW APPLICATION ENTERED | — |
| Oct 9, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |